The indications below including FDA-approved indications and compendial uses are considered a covered benefit provided that all the approval criteria are met and the member has no exclusions to the prescribed therapy. SPECIALTY GUIDELINE MANAGEMENT.
Https Www Paisc Com Userfiles Pai Documents Pharmacy Specialty 20drug 20list Pdf
Program Type Prior Authorization Quantity Limit Step Therapy.
Lorbrena specialty pharmacy. Anaplastic Lymphoma Kinase Inhibitor. It is not known if LORBRENA is safe and effective in. IC-0410 Last Review Date.
Your healthcare provider will perform a test to make sure that LORBRENA is right for you. Lorbrena lorlatinib Oral Document Number. Length of Authorization Coverage will be provided for six months and may be renewed.
If you prefer you and your staff can also continue to work directly with specialty pharmacies. This medication has been designated specialty and must be filled at a contracted specialty pharmacy. Description Of Product Lorlatinib Lorbrena Description.
800 323-2445 Hours of operation. MODERIBA MONOCLATE-P MONONINE MOZOBIL January 2019 Products distributed by CVS Specialty. Quantity Limit max daily dose Pharmacy Benefit.
LORBRENA is available in a 100-mg strength tablet and a 25-mg strength tablet. 3 tablets per day Lorbrena 100 mg tablets. Your healthcare provider will perform a test to make sure that LORBRENA is right for you.
Lorbrena lorlatinib Effective 01012021. LORBRENA is a prescription medicine that is used to treat people with non-small cell lung cancer NSCLC that is caused by an abnormal anaplastic lymphoma kinase ALK gene and that has spread to other parts of the body and who have taken the medicine. Plan MassHealth MassHealth PUF CommercialExchange.
05012019 Date of Origin. 800 269-5493 Hours of operation. Through our OncoSource program we can provide comprehensive access to oral injected and infused oncology medications including.
LORBRENA lorlatinib is a prescription medicine that is used to treat adults with non-small cell lung cancer NSCLC that is caused by an abnormal anaplastic lymphoma kinase ALK gene and that has spread to other parts of your body. LORBRENA is a prescription medicine that is used to treat adults with non-small cell lung cancer NSCLC that is caused by an abnormal anaplastic lymphoma kinase ALK gene and that has spread to other parts of your body. Contraception because Lorbrena can render hormonal contraceptives ineffective.
Males with female partners of reproductive potential should use effective contraception during treatment with Lorbrena for at least 3 months after the final dose. Clinical Pharmacy Program Guidelines for Lorbrena. We also provide free language interpreter services.
Lorbrena lynparza lysodren matulane mektovi mercaptopurine myleran nerlynx nexavar nilandron nilutamide ninlaro odomzo pomalyst purixan revlimid rydapt sprycel stivarga sutent tabloid tafinlar talzenna tarceva targretin temodar temozolomide thalomid tibsovo toremifene citrate tretinoin valchlor venclexta verzenio vitrakvi vizimpro votrient xalkori xeloda xospata. Lorbrena lynparza lysodren matulane tobi mekinist mektovi mercaptopurine myleran nerlynx nilandron nilutamide pomalyst purixan revlimid rubraca rydapt sprycel stivarga idelvion sutent ixinity tabloid jivi tafinlar tagrisso talzenna targretin tasigna novoeight temodar temozolomide thalomid obizur tibsovo profilnine sd tretinoin recombinate tykerb valchlor tretten venclexta. Onco360 is Your Single Source For All Of Your Oncology Hematology Pharmacy Needs.
Tyrosine Kinase Inhibitor CSA NA - FDA Approved REMS N Can Ship How Does It Work Lorlatinib Lorbrena is a potent reversible third generation tyrosine kinase inhibitor. The Comprehensive Specialty Pharmacy Drug List is a guide of medications available through CVS Specialty. Humana Pharmacy complies with all applicable federal civil rights laws and does not discriminate on the basis of race color national origin ancestry religion sex marital status gender gender identity sexual orientation age or disability.
LORBRENA LUCENTIS LUMIZYME LUMOXITI LUPANETA PACK LUPRON LUPRON DEPOT LYNPARZA M. Hier sollte eine Beschreibung angezeigt werden diese Seite lässt dies jedoch nicht zu. Injectable biosimilars are available through most major wholesalers.
MACUGEN MAKENA MAVYRET MEKINIST MENOPUR MICRHOGAM. Benefit Pharmacy Benefit Medical Benefit NLX Specialty Limitations. Onco360 offers a single sourcing solution for the complex multi-drug therapy regimens that make up todays cutting-edge cancer treatment protocols.
In addition we can help find a specialty pharmacy that can fill your prescription. BESPONSA inotuzumab ozogamicin and MYLOTARG gemtuzumab ozogamicin are available through a network of specialty distributors and specialty pharmacies. LORBRENA is a prescription medicine that is used to treat adults with non-small cell lung cancer NSCLC that is caused by an abnormal anaplastic lymphoma kinase ALK gene and that has spread to other parts of your body.
Women should not breastfeed during treatment with Lorbrena and for 7 days after the final dose. Lorbrena 25 mg tablets. Pfizer Oncology Together can help you understand your insurance and identify what financial support may be available for your prescribed LORBRENA.
Program Prior Authorization Medication Lorbrena lorlatinib Markets in Scope Arizona California Colorado Hawaii Maryland Nevada New Jersey New York New York EPP Pennsylvania CHIP Rhode Island South Carolina Issue Date 122018 Pharmacy and Therapeutics Approval Date 122020 Effective Date 12021. LORBRENA lorlatinib POLICY. FDA-Approved Indications Lorbrena is a kinase inhibitor.
